BRANDI BUSKIRK: Open Payments
NPI 1245530823 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $231 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Medtronic, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
Products named: Ozempic, CAPLYTA, Rybelsus, REVEAL LINQ, INGREZZA, Wegovy, VRAYLAR, ROTATEQ.
Industry payments across MI — which companies pay providers there.
